These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30071479)

  • 1. Dual antiplatelet and anticoagulant (APAC) heparin proteoglycan mimetic with shear-dependent effects on platelet-collagen binding and thrombin generation.
    Chen J; Verni CC; Jouppila A; Lassila R; Diamond SL
    Thromb Res; 2018 Sep; 169():143-151. PubMed ID: 30071479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell-derived heparin proteoglycans as a model for a local antithrombotic.
    Lassila R; Jouppila A
    Semin Thromb Hemost; 2014 Nov; 40(8):837-44. PubMed ID: 25393636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antiplatelet and anticoagulant APAC prevents experimental ischemia-reperfusion-induced acute kidney injury.
    Tuuminen R; Jouppila A; Salvail D; Laurent CE; Benoit MC; Syrjälä S; Helin H; Lemström K; Lassila R
    Clin Exp Nephrol; 2017 Jun; 21(3):436-445. PubMed ID: 27405618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice.
    Bonetti NR; Jouppila AS; Saeedi Saravi SS; Cooley BC; Pasterk L; Liberale LL; Gobbato S; Lüscher TF; Camici GG; Lassila RP; Beer JH
    Thromb Res; 2023 Aug; 228():163-171. PubMed ID: 37331119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions.
    Lassila R; Lindstedt K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3578-87. PubMed ID: 9437208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.
    Colace TV; Muthard RW; Diamond SL
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1466-76. PubMed ID: 22516070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan).
    Winzely M; Jouppila A; Ramer G; Lux L; Lendl B; Barreiro K; Lassila R; Friedbacher G
    Anal Bioanal Chem; 2022 Jan; 414(2):1029-1038. PubMed ID: 34773471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe
    Bot I; Delfos L; Hemme E; Bernabé Kleijn MNA; van Santbrink PJ; Foks AC; Kovanen PT; Jouppila A; Lassila R
    Atherosclerosis; 2024 Oct; 397():118567. PubMed ID: 39243663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Koide T; Maruyama I; Tanaka KA
    PLoS One; 2014; 9(1):e86491. PubMed ID: 24497951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
    Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
    Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition.
    Li R; Panckeri KA; Fogarty PF; Diamond SL
    Haemophilia; 2015 Mar; 21(2):266-274. PubMed ID: 25311576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC; Jiang X
    Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coimmobilized native macromolecular heparin proteoglycans strongly inhibit platelet-collagen interactions in flowing blood.
    Kauhanen P; Kovanen PT; Lassila R
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):E113-9. PubMed ID: 11073864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
    Pontiggia L; Steiner B; Ulrichts H; Deckmyn H; Forestier M; Beer JH
    Thromb Haemost; 2006 Dec; 96(6):774-80. PubMed ID: 17139372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin.
    Mehta AY; Mohammed BM; Martin EJ; Brophy DF; Gailani D; Desai UR
    J Thromb Haemost; 2016 Apr; 14(4):828-38. PubMed ID: 26748875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant leech antiplatelet protein specifically blocks platelet deposition on collagen surfaces under flow conditions.
    van Zanten GH; Connolly TM; Schiphorst ME; de Graaf S; Slootweg PJ; Sixma JJ
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1424-31. PubMed ID: 7670958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.
    Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V
    Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
    Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
    Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.